Analysis of tumor DNA markers in the plasma of colorectal cancer patients by liquid biopsy
Suspended
- Conditions
- C18C20Malignant neoplasm of colonMalignant neoplasm of rectum
- Registration Number
- DRKS00012890
- Lead Sponsor
- Medizinisch Genetisches Zentrum (MGZ)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Microsatellite stable colorectal cancer
Exclusion Criteria
Neoadjuvant radio or chemotherapy has already started
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of tumorspecific SCNAs in plasma samples of colorectal cancer patients
- Secondary Outcome Measures
Name Time Method Identification of tumorspecific hotspot mutations in plasma samples of colorectal cancer patients